Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 230 of 239
25434V500
Shares:6
Value:$359
% of Portfolio:0.0% ($359/$44.8B)
74915M209
Shares:53
Value:$352
% of Portfolio:0.0% ($352/$44.8B)
Werewolf Therapeutics, Inc.
Shares:355
Value:$345
% of Portfolio:0.0% ($345/$44.8B)
BIO KEY INTERNATIONAL INC
Shares:428
Value:$338
% of Portfolio:0.0% ($338/$44.8B)
DLH Holdings Corp.
Shares:83
Value:$336
% of Portfolio:0.0% ($336/$44.8B)
System1, Inc.
Shares:873
Value:$333
% of Portfolio:0.0% ($333/$44.8B)
COMPX INTERNATIONAL INC
Shares:16
Value:$331
% of Portfolio:0.0% ($331/$44.8B)
ZYNEX INC
Shares:150
Value:$330
% of Portfolio:0.0% ($330/$44.8B)
Cibus, Inc.
Shares:174
Value:$325
% of Portfolio:0.0% ($325/$44.8B)
294628102
Shares:198
Value:$319
% of Portfolio:0.0% ($319/$44.8B)
Verrica Pharmaceuticals Inc.
Shares:715
Value:$317
% of Portfolio:0.0% ($317/$44.8B)
Metagenomi, Inc.
Shares:231
Value:$314
% of Portfolio:0.0% ($314/$44.8B)
Ovid Therapeutics Inc.
Shares:1.0K
Value:$312
% of Portfolio:0.0% ($312/$44.8B)
ALX ONCOLOGY HOLDINGS INC
Shares:499
Value:$311
% of Portfolio:0.0% ($311/$44.8B)
92189F486
Shares:12
Value:$307
% of Portfolio:0.0% ($307/$44.8B)
Skye Bioscience, Inc.
Shares:190
Value:$302
% of Portfolio:0.0% ($302/$44.8B)
SolarMax Technology, Inc.
Shares:252
Value:$302
% of Portfolio:0.0% ($302/$44.8B)
Fortress Biotech, Inc.
Shares:193
Value:$301
% of Portfolio:0.0% ($301/$44.8B)
Airship AI Holdings, Inc.
Shares:77
Value:$297
% of Portfolio:0.0% ($297/$44.8B)
G6483G100
Shares:1.1K
Value:$289
% of Portfolio:0.0% ($289/$44.8B)